RETATRUTIDE 10MG
GLP-1 receptor
GIP receptor
Glucagon receptor
Retatrutide is an investigational (not yet FDA-approved) triple-agonist medication being studied for obesity and metabolic disease. It activates three different hormone receptors and tells your brain to slow them down and put you into fat burning mode. key points this does for you
Enhances insulin sensitivity and glucose metabolism
reduces appetite and food cravings
improves energy levels and fat oxidation
significant weight loss and targeting metabolic pathways
